Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.33 |
| ▸ | TEK | Q02763 | 1/20 | 0.33 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22980335 | 1.00 | ERBB2 (0.35) | ERBB2ALOX5PTGS2MAPTKDM4E | |
| SCHEMBL9911035 | 0.81 | PABPC1 (0.32) | MAPK1PKMTDP1 | |
| SCHEMBL9886534 | 0.81 | PABPC1 (0.32) | MAPK1PKMTDP1 | |
| SCHEMBL18143023 | 0.81 | PABPC1 (0.32) | MAPK1PKMTDP1 | |
| SCHEMBL9911034 | 0.81 | PABPC1 (0.32) | MAPK1PKMTDP1 | |
| SCHEMBL9886538 | 0.81 | PABPC1 (0.32) | MAPK1PKMTDP1 | |
| SCHEMBL7898065 | 0.74 | ACHE (0.47) | ERBB2ALOX5PTGS2MAPTKDM4E | |
| Hydrazine SCHEMBL28821631 | 0.71 | ACHE (0.44) | ERBB2MAPTKDM4EMEN1MAPK1 | |
| SCHEMBL9911033 | 0.69 | ERBB2 (0.34) | ERBB2 | |
| SCHEMBL9105522 | 0.69 | ERBB2 (0.34) | ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114787122-B | Novel fold condensation of 2-methoxymethyl-p-phenylenediamine | 威娜德国有限责任公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4013739-B1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | WELLA GERMANY GMBH (DE) | 2024-10-02 | — | — | EP | claimed |
| US-20220298101-A1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | WELLA GERMANY GMBH (DE) | 2022-09-22 | — | — | US | claimed |
| CN-114787122-A | Novel polycondensation synthesis of 2-methoxymethyl-p-phenylenediamine | 威娜德国有限责任公司 | 2022-07-22 | — | — | CN | claimed |
| EP-4013739-A1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | Wella Germany GmbH (DE) | 2022-06-22 | — | — | EP | claimed |
| WO-2021028506-A1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | COTY INC. (US) | 2021-02-18 | — | — | WO | claimed |
| CN-114787122-B | Novel fold condensation of 2-methoxymethyl-p-phenylenediamine | 威娜德国有限责任公司 | 2025-03-21 | — | — | CN | disclosed |
| US-12122734-B2 | Telescoping syntheses of 2-methoxymethyl-p-phenylenediamine | WELLA GERMANY GMBH (DE) | 2024-10-22 | — | — | US | disclosed |
| EP-4013739-B1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | WELLA GERMANY GMBH (DE) | 2024-10-02 | — | — | EP | disclosed |
| US-20220298101-A1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | WELLA GERMANY GMBH (DE) | 2022-09-22 | — | — | US | disclosed |
| CN-114787122-A | Novel polycondensation synthesis of 2-methoxymethyl-p-phenylenediamine | 威娜德国有限责任公司 | 2022-07-22 | — | — | CN | disclosed |
| EP-4013739-A1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | Wella Germany GmbH (DE) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021028506-A1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | COTY INC. (US) | 2021-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12122734-B2 | Telescoping syntheses of 2-methoxymethyl-p-phenylenediamine | PNMT, TYR, DDT | ERBB2 588/4885ALOX5 3527/4885PTGS2 2196/4885 |
| US-20220298101-A1 | NEW TELESCOPING SYNTHESES OF 2-METHOXYMETHYL-P-PHENYLENEDIAMINE | PNMT, TYR, DDT | ERBB2 446/4885ALOX5 3169/4885PTGS2 2487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.